Streetbeat News

Stock Prices

VTYX

Ventyx Biosciences' stock dropped after its Phase 2 trial for VTX958 in Crohn's disease failed to meet the primary endpoint. The company is seeking a partner to continue development.

Portfolio Pulse from Vandana Singh

July 29, 2024 | 3:03 pm

BTCUSD

MCD

TSLA

Bitcoin rises following support from Trump, McDonald's stock declines after missing earnings expectations, and Morgan Stanley reiterates a bullish rating on Tesla.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 3:03 pm

ARUSD

Arweave (CRYPTO: AR) has seen a price increase of 4.71% in the past 24 hours, reaching $31.96. Despite a 44% drop in trading volume over the past week, the coin's circulating supply has only decreased by 0.18%. Arweave's market cap is currently $2.10 billion, ranking it #50.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:02 pm

SNOW

Whales have shown unusual options activity for Snowflake (NYSE:SNOW), with a mix of bullish and bearish trades. Analysts have set a consensus target price of $198.33, with individual targets ranging from $165 to $220. The stock is currently trading at $128.96, down by 0.03%, and may be approaching oversold territory.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:02 pm

SMCI

Whales are taking a bearish stance on Super Micro Computer (NASDAQ:SMCI) with significant options trades. 37% of trades are bearish, with a notable amount of puts. Analysts have mixed ratings, with Nomura lowering its rating to Neutral and Susquehanna maintaining a Negative rating.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:02 pm

DXCM

Whales have taken a bearish stance on DexCom (NASDAQ:DXCM) with 47% of recent options trades being bearish. The trading activity suggests a price range of $45.0 to $110.0 for DXCM over the next three months. Analysts have mixed ratings, with price targets ranging from $75 to $145.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:02 pm

IMXUSD

Immutable (IMX) has seen a 5.04% price increase in the past 24 hours, reaching $1.53, despite a 2.0% loss over the past week. The trading volume has decreased by 20.0%, and the circulating supply has fallen by 0.21%. The current market cap is $2.36 billion, ranking #47.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:01 pm

BTCUSD

Bitcoin's recent surge towards $70,000 has prompted traders to discuss strategies to avoid buying at the top. While some traders expect further gains, others predict a short-term correction. Key economic events this week, including the Federal Reserve's interest rate decision and the U.S. unemployment rate announcement, are likely to influence crypto prices.

Portfolio Pulse from Khyathi Dalal

July 29, 2024 | 3:01 pm

BEN

Analysts have provided mixed ratings for Franklin Resources (NYSE:BEN) over the past three months, with a majority being indifferent. The average 12-month price target has decreased by 6.32% to $24.0. Analysts from Keefe, Bruyette & Woods, BMO Capital, UBS, and TD Cowen have all lowered their price targets and ratings. Franklin Resources has shown revenue growth but lags behind industry peers in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 3:01 pm

CGTX

Cognition Therapeutics shares are trading lower after the company reported data from its Phase 2 SHINE trial of CT1812 in Alzheimer's. CT1812 did not achieve statistical significance on the first of the ordered secondary efficacy endpoints.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 3:01 pm